Abstract Impairment of vascular growth is a hallmark of diabetic complications, but the progression and mechanisms are poorly understood. To determine whether obesity and early diabetes impair endothelium-dependent vasodilatation and vascular response to ischemia, microvascular function as well as angiogenic responses to ischemia were assessed in young (C57) and 6-month-old lean mice (old C57), in obese (db-C57) mice, and in mice suffering an early (db-KsJ) and sustained type 2 diabetes (old db-KsJ). Glycemia gradually increased from the db-C57 to the old db-KsJ. Early and established type II diabetes significantly reduced the level of insulin that was significantly increased in obese mice. Endothelial function was assessed in isolated resistance arteries while the angiogenic response induced by unilateral hindlimb ischemia was analyzed, after 28 days, with a laser Doppler flowmeter and angiography. Aging (-21%), obesity (-45%), as well as early (-58%) and sustained type II diabetes (-69%) induced a progressive impairment of the endothelium-dependent relaxation of the gracilis artery. Laser Doppler measurements demonstrated that only early and sustained type II diabetes impaired skin blood flow recovery. Vascular collateralization was reduced with aging and severely impaired in older db-KsJ mice, the two strains of mice in which ischemia reduced eNOS expression. These results demonstrate that endothelial dysfunction induced by obesity is insufficient to alter the angiogenic response to ischemia. Furthermore, the development of frank type II diabetes or increasing age is required to impair the vascular response to hindlimb ischemia. We conclude that additional risk factors or severe endothelial dysfunction may be requisite to impede the angiogenic response to ischemia.
Introduction
Obesity and diabetes are the greatest emerging risk factors for cardiovascular disease in Western nations [42, 43] . The manifestations of this affliction include exacerbation of both macrovascular and microvascular dysfunction [26, 29] . A physiological consequence of microvascular disease is impaired angiogenesis and wound healing. While frank diabetes [10, 30, 39, 40] is well-documented to impair vascular adaptation to injury and ischemia, the extent to which earlier forms of obesity and metabolic dysfunction impair vascular adaptation are incompletely understood.
Vascular adaptations to ischemia involve adjustments in large vessels (collateralization) and small vessels (angiogenesis). A central theme in failure of vascular adaptation is endothelial dysfunction, particularly loss of NO signaling. Angiogenesis is impaired in mice null for the endothelial NO synthase (eNOS) gene [28] and administration of eNOS antagonists impairs collateral growth [25, 48] . Induction and/or over-expression of eNOS protect vascular adaptation under pathologic conditions where it is impaired [6, 22, 36, 45] . Because diabetes impairs NO-mediated vasodilation and related functions, it is commonly thought that loss of NO-signaling is the link between diabetes and its associated deficits in vascular adaptation to ischemia or injury.
Frank diabetes (fixed hyperglycemia, declining insulin production) is preceded by a prolonged state of insulin resistance/early diabetes (mild hyperglycemia, hyperinsulinemia). The insulin-resistant state is commonly linked to obesity and obese, insulin-resistant individuals, both patients and animal models, show an impaired vasodilation to endothelium-dependent agonists [5, 7, 14, 19, 37] . Such impairment begs the question: is insulin resistance/early diabetes sufficient to impair vascular adaptation to ischemia?
The goal of the current study was to test the hypothesis that obesity and early diabetes impair endotheliumdependent vasodilation and the vascular response to ischemia. Animal models were selected to take advantage of a natural variance in diabetic progression in the db/db mouse strain. db/db mice on the C57BL/6J background (db-C57), with modest hyperglycemia and high levels of insulin, were used to model obesity and early stages of diabetes. db/db mice on C57BL/KsJ background (db-KsJ) were used to mimic more pronounced diabetes. db-KsJ mice at 6 months of age (old db-KsJ) were used to mimic advanced diabetes. Endothelium-dependent reactivity was assessed in vitro using a resistance artery of the lower limb (gracilis artery). Vascular adaptation to ischemia was assessed using femoral artery ligation and two indices of vascular recovery: skin blood flow via laser Doppler and collateral formation via X-ray angiography. Taken together, these data provide new examination of the relationship between the progression of diabetes and vascular adaptation to ischemia.
Materials and methods

Model of insulin resistance
Different levels of insulin resistance were obtained by using either db/db mice on a C57Bl/6J background (db-C57, 3 months old) or on a KsJ background (db-KsJ, 3 or 6 months old), all purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Experimental groups were compared to their aged-match littermates (C57 mice, 3 or 6 months old, on a KsJ background) as controls. Animals were fed standard mice chow and tap water was provided ad libitum. Mice were housed in the American Association of Laboratory Animal Care-approved animal care facility of the Medical College of Georgia, and the Institutional Animal Care and Use Committee approved all protocols.
Metabolic profile
To assess the metabolic status as an index of diabetic progression, mice fasted overnight were anesthetized by isoflurane in a rapid induction chamber and swiftly decapitated. Fasting blood glucose was assessed with a Precision Glucometer (Medisense, Bedford, MA, USA). Trunk blood was collected in heparin and rapidly centrifuged at 4°C to remove blood cells and obtain plasma. Samples were frozen for later analyses. Plasma cholesterol and triglycerides were determined using colorimetric assays from Wako Chemicals (Richmond, VA, USA). Plasma insulin and TNFa concentrations were determined using ELISA assay kits from Alpco Diagnostics (Windham, NH, USA) and Alpha Diagnostic (San Antonio, TX, USA), respectively.
Induction of hindlimb ischemia
Surgery was performed under isoflurane anesthesia (2%) to create unilateral hindlimb ischemia in the mice according to techniques previously described [1, 8, 35, 40] . Briefly, an incision in the skin overlying the middle portion of the right hindlimb of each mouse exposed the femoral artery. The femoral artery was ligated (6.0 silk suture), and sectioned proximal to the bifurcation to the saphenous and popliteal arteries. The overlying skin was then closed and care was taken to avoid any infection.
Measurement of skin perfusion
To evaluate neovascularization, laser Doppler perfusion imaging experiments (Periscan Pim 3 system, Perimed, Järfälla, SWEDEN) were performed under isoflurane anesthesia (2%) before, just after the ligation of the femoral artery and on days 7, 14, 21 and 28. Mice were placed on a heating pad at 37°C to minimize temperature variation. Blood flow was displayed as change in the laser frequency, represented by different color pixels. The intensity of the signal, proportional to the skin blood flow, was calculated in the foot and expressed as a ratio of ischemic (right) to nonischemic (left) leg. Four to six pictures were taken per animal and per day of measurement. The images were then averaged to determine the level of perfusion of each leg.
Angiography: measurement of ischemia-induced collateralization Arterial density was evaluated by high-definition angiography 14 and 28 days after ligation. Mice were anesthetized and a contrast medium (barium sulfate, 1 g/ml) was infused, in vessels dilated with sodium nitroprusside (0.1 mg/kg), through a catheter introduced into the abdominal aorta as previously described [1, 35, 39, 40] . Images were acquired using a digital X-ray transducer (Kodak Image station, 4000 MM, Carestream Health Inc.). The angiogram of each mouse was scored by five blinded operators. A score between 0 (no angiogenesis, a picture taken just after the section of the femoral artery was used as a control) and 4 (vascular density equal or superior in the ischemic leg compared to the control leg) was attributed to each picture. Values obtained for each mouse were averaged and the mean value of each group was calculated.
Assessment of the endothelial function
Hindlimb resistance arteries (gracilis artery, *120 lm passive internal diameter) (n = 6 per group) was surgically dissected and bathed in Krebs-Ringer bicarbonate solution composed of (in mM) 118.3 NaCl, 4.7 KCl, 2.5 CaCl 2 , 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 25 NaHCO 3 , and 11.1 dextrose. The artery was mounted in a vessel bath between two glass micropipettes (*100-lm-diameter tip) and secured with 10-0 silk ophthalmic suture. The lumen of the vessel was filled with Krebs buffer through the micropipette and maintained at a constant pressure of 60 mmHg as described previously [31] . Vessels were monitored under a Nikon inverted light microscope connected to a video monitor. Internal diameter was continually measured using a video dimension analyzer (Texas, A&M). A serial dose-response curve to acetylcholine (ACh) was generated (over the following dose ranges: 0.1 nM to 10 mM) to asses the endothelium-dependent relaxation. The contribution of NO and cyclooxygenase derivatives to the endothelium-dependent relaxation were studied by repeating the dose-response curve to ACh, in the presence of L-NAME (100 lM) and L-NAME ? indomethacin (10 lM). The passive diameter was obtained after full relaxation of the vessel induced by sodium nitroprusside in a Ca 2? -free Krebs solution. Vasodilation was expressed in percentage of the myogenic tone, which was calculated as the difference between the active and the passive diameters, at the pressure of 60 mmHg, and expressed in percent of the passive diameter.
Western blotting
At the end of the experiment, muscle samples (gastrocnemius) were dissected from the control and ischemic legs, snap frozen in liquid nitrogen immediately after extraction and pulverized. Proteins were solubilized in a lysis buffer containing 1% Nonidet P-40, 0.1% SDS, 0.1% deoxycholate, 50 mM Tris-HCl, 0.1 mM EGTA, 0.1 mM EDTA, 5 mM sodium fluoride, 1 mM sodium pyrophosphate, 1 mM sodium vanadate, 1 mmol 4-(2-aminoethyl)-benzenesulfonyl fluoride, and a protease inhibitor cocktail tablet (Roche Diagnostics, Mannheim, Germany), pH 7.5. Insoluble protein was removed by centrifugation, and protein content in the supernatants was quantified using the Lowry method with bovine serum albumin as the standard. Proteins were size fractionated by SDS-PAGE and immunoblotted with antibodies to serine 1177-phosphorylated eNOS, eNOS and GAPDH (BD Biosciences). The intensities of the bands corresponding to the proteins of interest were measured using densitometry. Data are expressed as percent of the control leg.
Statistics
All data are presented as means ± SE. Differences in means among groups for non-repeated variables (metabolic parameters) were compared by one-way ANOVA. Differences in means among groups with repeated variables (changes in skin blood flow recovery, ACh relaxation) were compared by one-way ANOVA with repeated measures. Scheffe's test was used as the post hoc test (STATVIEW).
Results
Metabolic phenotype
As shown in Table 1 , body weight was significantly increased in all db-C57 compared to C57 mice. The 3-month-old db-C57 and db-KsJ were similar in body weight while the 6-month-old db-KsJ mice presented an increased body weight compared to both younger db-KsJ (3 months old) and to their aged-matched littermate control (C57). As an index of metabolic dysfunction, glycemia increased from the young C57 to the db-KsJ mice. Aging by itself did not impair glycemic status as reflected by the lack of difference in the fasting glycemia between young and old C57 as well as between young and 6-month-old dbKsJ. Plasma insulin concentration was used as an index of insulin resistance. Consistent with obesity-induced insulin resistance, insulin levels were markedly increased in 3-month-old db/db mice on c57 background. However, early type II diabetes as evident in the 3-month-old db-KsJ mice was associated with significantly decreased insulinemia, a reduction that was significantly exaggerated with aging in this type II diabetic mouse (old db-KsJ). Obesity induced an increase in triglycerides level above that of the lean and frankly diabetic mice. Plasma cholesterol concentration was significantly increased in db-C57, 6-monthold db-KsJ and old C57 on a KsJ background. As an index of the systemic inflammation, plasma TNFa levels were determined. TNFa plasma levels were markedly increased with obesity relative to all other groups. While sustained type II diabetes (6-month-old db-KsJ) induced a moderate increase in TNFa, diabetes at a young age (db-KsJ) did not affect TNFa level. This outcome is consistent with the work of Zhang and colleagues [47] who observed that obesity, but not more advanced diabetes, resulted in In lean C57 mice, ligation of the femoral artery reduced perfusion by 82 ± 2% (P \ 0.001) of baseline values. Initial reductions in perfusion were similar in all mice studied (C57, 82 ± 2%; db-C57, 83 ± 2; db-KsJ, 83 ± 2%; old db-KsJ, 84 ± 1%, NS). In 3-month-old lean C57 mice, skin perfusion recovered incrementally over a 4-week period, reaching a level 151 ± 15% of occluded baseline (P \ 0.001). Aging in lean mice (C57 on a KsJ background) had no effect on vascular adaptation to ischemia as assessed by laser Doppler. In comparison to the age-matched lean C57BL/6J mice (C57), the db/db mice on a C57BL/6J background (db-C57) at 3 months of age (obesity, minimal hyperglycemia), presented a similar skin blood flow recovery (C57: 151 ± 15% vs. db-C57: 139 ± 18, NS), indicating that obesity and mild hyperglycemia are insufficient to impair vascular adaptation to ischemia. In 3-month-old db/db mice on C57BL/KsJ background (db-KsJ, obesity, moderate hyperglycemia), section of the femoral artery induced a similar drop in perfusion to lean mice but recovery at 28 days was 57% that observed in 3-month-old lean mice (C57: 151 ± 15% vs. db-KsJ: 48 ± 18, P \ 0.05). In 6-month-old db/db mice on C57BL/KsJ background (old db-KsJ, obesity, prolonged hyperglycemia), ischemia induced a similar drop in Table 1 Metabolic parameters obtained for the young (C57, n = 15) and old lean control mice (old C57, n = 6), the obese mice (db-C57, n = 6) and the mice suffering an early (db-KsJ, n = 6) or prolonged type II diabetes (old db-KsJ, n = 6) perfusion to 6-month-old lean mice but recovery at 28 days was 39% that observed in lean mice on the C57BL/KsJ background (old C57: 186 ± 21% vs. old db-KsJ: 38 ± 10%, P \ 0.05). Aging did not further impair skin blood flow recovery in the db-KsJ mice (db-KsJ: 48 ± 18 vs. old db-KsJ: 38 ± 10%, NS).
Effect of progressive diabetes on vascular collateralization
Angiography was used to evaluate the vascular collateralization after 14 and 28 days of hindlimb ischemia. Figure 2a includes representative X-ray pictures of the vascular collateralization and Fig. 2b shows summary data. Figure 2a reports that C57, db-C57 and db-KsJ mice were able to develop a new vascular network in response to ischemia while old db-KsJ mice presented significant reduction in of the collateralization even after 28 days. This was reflected by the lack of vascular tree in the ischemic leg of the old db-KsJ mice. A trend towards a reduction of vascular collateralization (P = 0.0945) was noticed in 6-month-old lean C57 on a KsJ background.
Effect of progressive diabetes on vascular structure and endothelial function
Resistance arteries of the hindlimb (gracilis arteries) were cannulated on a pressurized myograph to determine their structure, myogenic tone and endothelial function. Figure 3a demonstrates that obesity, as well as type II diabetes and aging affect similarly vascular structure by inducing a *20% reduction in intraluminal diameter. While obesityinduced vascular remodeling was not associated with a modification of the myogenic tone, type II diabetes (db-KsJ) induced a 250% increased in myogenic tone that was not further increased in the 6-month-old db-KsJ (Fig. 3b) . Nevertheless, aging per se enhanced vascular tone (old C57, ?150%).
The endothelial function was assessed through the relaxation induced by acetylcholine. In lean C57 mice, ACh induced a maximal relaxation of 71 ± 2% (ACh, 10 lM). Aging in lean mice modestly reduced the endotheliumdependent relaxation by 21% (C57, 71 ± 2% vs. old C57, 56 ± 1%). Obesity, early type II diabetes and sustained type II diabetes induced a progressive and significant impairment of the endothelial function compared to the lean mice. Indeed, they respectively reduced the ACh-mediated dilation by 45% (db-C57), 58% (db-KsJ) and 69% (old db-KsJ). The endothelial dysfunction induced by early or sustained type II diabetes was higher than that observed in obese mice. Moreover, aging exaggerated the impairment of the endothelial function induced by type II diabetes (db-KsJ, 30 ± 3%; old db-KsJ, 22 ± 2% of relaxation for a concentration of ACh of 10 lM).
To determine the contribution of NO and cyclooxygenase to endothelium-dependent relaxation, the concentration-response curves to ACh were repeated in the presence of L-NAME and L-NAME ? indomethacin. As shown in Fig. 4 , in the presence of 100 lM L-NAME, maximum vasodilation was similar in all groups (C57: 22 ± 3 vs. db-C57: 17 ± 2 vs. db-KsJ: 17 ± 2%, NS), suggesting that the differences in vasodilator behavior among these groups represents differences in the action of nitric oxide. Small but statistically resolvable differences were observed with indomethacin after L-NAME in lean C57 (22 ± 3 vs. 10 ± 2, P \ 0.05) and db-KsJ (17 ± 2 vs. 8 ± 2%, P \ 0.05), when compared to L-NAME alone. Overall, cyclooxygenase products account for less than 15% of the dilation in any group.
Effect of ischemia and progressive diabetes on eNOS expression and activity
To further analyze the role of NO and endothelial function in the vascular response to ischemia, eNOS expression and phosphorylation (ratio peNOS/eNOS) were determined in control and ischemic legs by western blot analysis. As shown in Fig. 5a , while obesity (db-C57) decreased eNOS expression in the control leg only, aging (old C57, KsJ background) significantly reduced eNOS expression in the control and the ischemic leg. Ischemia affected eNOS expression in the obese group only by increasing its expression. However, the activation of eNOS by phosphorylation was similar in all groups, with no difference between the ischemic and control leg (Fig. 5b) .
Discussion
Vascular adaptation in response to ischemia is an important compensation for preserving tissue oxygenation and health. In the current study, we analyzed the effects of progressive stages of insulin resistance and diabetes on the vascular adaptation to hindlimb ischemia. There are three key observations in the current study: (1) The prolonged obesity and diabetes developed by the 6-month-old db-KsJ mice, impairs skin blood flow recovery and vascular tree regeneration, (2) early stages of diabetes (db-KsJ, severe hyperglycemia, insulin deficit) impairs skin blood flow recovery but not collateral formation and (3) despite impaired endothelial function, vascular adaptation to ischemia was normal in obese, insulin-resistant mice (db-C57). Relevant to these observations are the methods, the progression of diabetes and the role of nitric oxide in vascular injury.
Disruption of leptin action by the mutation of its receptor (db), in mice, leads to a hyperphagia-induced obesity and promotes the generation of insulin resistance and diabetes. In mouse models, the severity of the insulin resistance and the rate of progression of diabetes are determined by the background on which the mutation is produced. The C57BL/6J genome moderates hyperglycemia, while the C57BL/KsJ background accelerates this condition triggering the development of an early type II diabetes [4, 17, 21] . In agreement with the work cited above, we observed a progressive increase in body weight and glycemia from the C57 mice to the db-C57 and the db-KsJ that was exaggerated by age (Table 1) . Furthermore, as previously reported [3, 18] , type II diabetes (db-KsJ) induced a progressive decrease in insulin level compared to the obese mice (db-C57, Table 1 ). Thus, the three types of mice used in this study (db-C57, db-KsJ, and old db-KsJ) provide a good model to analyze the effects of a gradual increase in insulin resistance on vascular function and to dissociate the effects of obesity from those of type II diabetes in the impaired angiogenic response to ischemia. The vascular response to ischemia was assessed by inducing a hindlimb ischemia through the section of the femoral artery, an approach having the advantage of allowing the comparison of an ischemic to a control leg in the same animal [8] . When applied in mice suffering from prolonged type II diabetes (6-month-old db-KsJ), we observed a significant impairment of the skin blood flow recovery (Fig. 1) , the vascular collateralization (Fig. 2) and endothelial function (Fig. 4) . These deficits were associated with severe metabolic dysfunction and reduction in eNOS expression, likely explaining the reduced ability of the residual vascular network to grow in response to ischemic stress in the 6-month-old db-KsJ mice. Although the reduced angiogenic response associated with severe type II diabetes has been previously reported [20, 23, 32] , none of the cited studies determined the role played by obesity and the gradual progression of diabetes in the development of the impaired angiogenic response. In the current study, we observed that the early phase of type II diabetes (db-KsJ) mainly affects skin blood flow recovery (Fig. 1) . These data are consistent with previous observations of a reduced a Endothelium-dependent relaxation of the gracilis artery. Cumulative concentration-response curve to acetylcholine (ACh) performed with young (C57, n = 6) and 6-month-old lean control mice (old C57, n = 6), the obese mice (db-C57, n = 6) and the mice suffering an early (db-KsJ, n = 6) or prolonged type II diabetes (old db-KsJ, n = 6). In C57 (b), db-C57 (c) and db-KsJ (d) mice, concentrationresponse curve to ACh were repeated in the presence of L-NAME and L-NAME ? indomethacin. Data are presented as mean ± SEM. * P \ 0.05 versus C57, $ P \ 0.05 versus db-C57, # P \ 0.05 versus db-KsJ, £ P \ 0.05 versus old C57, ¥ P \ 0.05 versus control conditions, à P \ 0.05 versus L-NAME
angiogenic capacity [32] and of a diminished skin wound healing in the same animal model [15] . Similar observations were done in human, in which an impairment of the skin perfusion has been shown to be proportional to the progression of diabetes [33] . To date, revascularization at the level of larger collateral arteries has not been examined. The angiograms performed in the present study (Fig. 2) reveal that early type II diabetes (db-KsJ) has little to no effect on vascular collateralization. The most probable explanation of preserve collateral function in muscle despite loss of cutaneous perfusion assessed by Doppler is that core muscle perfusion is favored over skin perfusion.
Most interestingly, the present study showed that obesity (db-C57) with only moderate hyperglycemia, neither affects skin blood flow recovery nor the vascular collateralization in response to hindlimb ischemia, although a significant reduction in the endothelial function was noted in these mice. Similar results were obtained in the 6-month-old lean mice (old C57, KsJ background) whose skin blood flow recovery was also not altered despite an impaired endothelial function. Furthermore, as shown by Bouvet et al. [5] , obese Zucker rats (Zucker fa/fa) are able to remodel the structure of their resistance arteries in response to a chronic increase in blood flow, despite a diminished endothelial function. These latter data support the fact that the moderate endothelial dysfunction induced by obesity is insufficient to affect the ability of the vasculature to remodel its structure. The relation between the level of endothelial dysfunction and the ability of the vasculature to remodel is further supported by the study of Belin de Chantemele et al. [2] reporting that the severe endothelial dysfunction induced by type II diabetes abolished the ability of resistance artery to respond to chronic changes in flow. All together, the data of the present study and of the studies cited [2, 5] suggest that a threshold of vascular dysfunction is required to impede vascular remodeling in response to ischemia or in response to chronic changes in blood flow. According to the present data, a reduction of the endothelial function greater than 50% is required to impair the angiogenic response to ischemia.
The results of the present study also suggest that even if the increase in glycemia, triglycerides and cholesterol, induced by obesity might promote the endothelial dysfunction, they are not enough to impair the angiogenic response to ischemia. These results suggest that in our mouse model, the angiogenic response is not correlated to the cholesterol and triglycerides level contrary to what has been reported in rat [9] and rabbits [41] .
Of particular interest in this study is the plasma concentration of TNFa (Table 1 ). This cytokine is increased in obesity and blockade of its actions by specific anti-sera corrects endothelial dysfunction in obesity [16] . In the current study, we find that obesity, but not frank diabetes, is associated with increased TNFa. While the concept that TNFa plays a greater role in endothelial dysfunction early in the progression of diabetes rather than later is supported by our observations and that work of Zhang et al. [46, 47] , our absolute plasma concentrations are not concordant. We observe high TNFa with obesity but not in age-matched diabetes, whereas Zhang et al. [46, 47] observe increasing TNFa levels with increasing age. The reasons for this discordancy are not clear, but may relate to the different type of comparisons in these two studies; increasing diabetes in obesity via genetics versus aging. Whatever, the explanation, these observations underscore the complexity There are several explanations for the observation that obesity and mild diabetes are insufficient to impede vascular adaptation to ischemia. The first and simplest is that the degree of endothelial dysfunction induced by obesity and/or advancing age is inadequate to limit NO production sufficiently to impede vascular remodeling. Using these data as an index, and as suggested above, it would appear that a greater than 50% reduction of the endothelial function is required to impede the vascular response to ischemia. Another possibility is that aging and diabetes worsen perfusion by increasing myogenic tone. Indeed both db-KsJ and 6-month-old db-KsJ mice presented a 3.5-fold increase in their myogenic tone (Fig. 3b) . Moreover, there is evidence of vascular remodeling (reduction in intraluminal diameter) similar to that observed in obese mice (Fig. 3a) . This reduction in diameter as well as the reduced capillary density induced by obesity [11] [12] [13] might exaggerate the reduced vascular perfusion induced by obesity (reflected by the hypotrophic remodeling, [38] ) and impede the ability of the vessels to grow in response to ischemia, mechanism that requires increased vascular conductance and relaxation of the vascular tree [24] . Despite their appearance during the stage of obesity, vascular remodeling and capillary rarefaction appear to have no functional consequence on the ischemic angiogenic response, but may worsen the vascular adaptation to ischemia during the sustained stages of diabetes or contribute to other forms of angiogenesis such as exercise-induced changes in vascularity.
Alternatively, it may indicate the additional risk factors combined with endothelial dysfunction, are required. A key difference between db-C57 that did not develop an impaired angiogenesis and the young and old db-KsJ that presented a reduced vascular response to ischemia, is the plasma insulin level. Indeed insulin level was lower in the young and old type II diabetic mice compared to the obese mice. Through the control of the glycemia, insulin regulates the formation of advanced glycation end products (AGEs) and the degree of inflammation, factors that both have been closely related to impaired vascular function and response to ischemia [34] . In addition to control of glucose metabolism, insulin is also a vasoactive hormone that induces arteriole relaxation [27] and promotes growth and formation of microvessels through the stimulation of VEGF expression and NO release [44] . Reduction in insulin level, combined with the inability to respond to insulin in insulin-resistant mice, might affect these two NO-dependent pathways and reduce the ability to respond to ischemia. Due to the metabolic and vascular effects of insulin, the preservation of its level and sensitivity is crucial for the prevention of microvascular dysfunction and vascular response to ischemia. In summary, this study reports for the first time the progression of endothelial impairment and vascular adaptation to ischemia in obesity-induced metabolic dysfunction. The results of these studies indicate that while obesity, insulin resistance and diabetes progressively worsen endothelial function and vascular responses to femoral occlusion, endothelial dysfunction induced by obesity and insulin resistance is insufficient to reduce the ability of the lower limb to adapt to ischemia. The progressive loss of perfusion in diabetes may reflect higher levels of endothelial dysfunction or other factors associated with the frankly diabetic state.
